Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix Announces Leadership Transition

See Release

All News

Archives

Endologix Announces Reinstatement of CE Mark for its Nellix EndoVascular Aneurysm Sealing System

Endologix Announces Equity Financing of $52 Million and Debt Restructuring Addressing 2020 Maturities and Financial Covenants

Endologix Provides Update on Previously Announced Voluntary Nellix System Recall

Endologix Appoints John D. Zehren as Chief Commercial Officer

Endologix Takes Decisive Action to Optimize Patient Outcomes by Ensuring Nellix System Used Only within Current Indications